NUS Change In Cash vs Cash And Cash Equivalents Changes Analysis
NUS Stock | USD 11.83 0.07 0.60% |
Nu Skin financial indicator trend analysis is infinitely more than just investigating Nu Skin Enterprises recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nu Skin Enterprises is a good investment. Please check the relationship between Nu Skin Change In Cash and its Cash And Cash Equivalents Changes accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
Change In Cash vs Cash And Cash Equivalents Changes
Change In Cash vs Cash And Cash Equivalents Changes Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nu Skin Enterprises Change In Cash account and Cash And Cash Equivalents Changes. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Nu Skin's Change In Cash and Cash And Cash Equivalents Changes is 0.98. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Cash And Cash Equivalents Changes in the same time period over historical financial statements of Nu Skin Enterprises, assuming nothing else is changed. The correlation between historical values of Nu Skin's Change In Cash and Cash And Cash Equivalents Changes is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Nu Skin Enterprises are associated (or correlated) with its Cash And Cash Equivalents Changes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Cash Equivalents Changes has no effect on the direction of Change In Cash i.e., Nu Skin's Change In Cash and Cash And Cash Equivalents Changes go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Change In Cash
Cash And Cash Equivalents Changes
Most indicators from Nu Skin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. At this time, Nu Skin's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.37 in 2024, despite the fact that Tax Provision is likely to grow to (16.1 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.0B | 1.6B | 1.4B | 1.4B | Total Revenue | 2.7B | 2.2B | 2.0B | 1.8B |
Nu Skin fundamental ratios Correlations
Click cells to compare fundamentals
Nu Skin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nu Skin fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 2.0B | 1.9B | 1.8B | 1.8B | 1.2B | |
Other Current Liab | 270.1M | 366.6M | 339.1M | 253.2M | 216.1M | 214.0M | |
Total Current Liabilities | 356.8M | 542.9M | 529.7M | 359.2M | 328.9M | 305.0M | |
Total Stockholder Equity | 875.3M | 894.3M | 912.8M | 897.3M | 822.0M | 572.2M | |
Property Plant And Equipment Net | 597.9M | 653.5M | 574.6M | 543.5M | 523.1M | 263.7M | |
Net Debt | 132.0M | 97.7M | 125.4M | 214.3M | 351.3M | 368.8M | |
Retained Earnings | 1.7B | 1.8B | 1.9B | 1.9B | 1.9B | 1.0B | |
Accounts Payable | 39.0M | 66.2M | 50.0M | 54.0M | 43.5M | 34.4M | |
Cash | 335.6M | 402.7M | 339.6M | 264.7M | 256.1M | 248.8M | |
Non Current Assets Total | 1.0B | 1.1B | 1.0B | 1.1B | 1.1B | 607.7M | |
Non Currrent Assets Other | 154.0M | 50.6M | 113.1M | 115.2M | 110.0M | 104.5M | |
Cash And Short Term Investments | 344.0M | 423.9M | 354.8M | 278.5M | 267.8M | 256.4M | |
Net Receivables | 50.4M | 63.4M | 41.3M | 47.4M | 72.9M | 76.5M | |
Common Stock Shares Outstanding | 55.9M | 52.8M | 51.4M | 50.5M | 49.9M | 54.3M | |
Liabilities And Stockholders Equity | 1.8B | 2.0B | 1.9B | 1.8B | 1.8B | 1.2B | |
Non Current Liabilities Total | 537.0M | 519.9M | 464.0M | 564.4M | 655.6M | 688.4M | |
Inventory | 275.9M | 314.4M | 399.9M | 346.2M | 280.0M | 187.9M | |
Other Current Assets | 69.9M | 14.7M | 76.9M | 87.8M | 71.0M | 65.8M | |
Other Stockholder Equity | (767.3M) | (881.8M) | (925.2M) | (955.8M) | (948.6M) | (901.2M) | |
Total Liab | 893.7M | 1.1B | 993.7M | 923.7M | 984.5M | 586.6M | |
Total Current Assets | 740.2M | 903.2M | 873.0M | 759.9M | 691.6M | 551.1M | |
Short Long Term Debt Total | 467.7M | 500.4M | 465.0M | 479.0M | 607.3M | 637.7M | |
Short Term Debt | 27.5M | 75.0M | 107.5M | 25M | 48.9M | 51.8M | |
Property Plant And Equipment Gross | 597.9M | 653.5M | 453.7M | 444.8M | 897.6M | 942.5M | |
Accumulated Other Comprehensive Income | (85.3M) | (64.8M) | (73.9M) | (86.5M) | (100.0M) | (105.0M) | |
Intangible Assets | 80.3M | 89.5M | 77.0M | 66.7M | 105.3M | 84.0M | |
Other Liab | 96.8M | 102.3M | 106.5M | 98.3M | 113.0M | 72.4M | |
Other Assets | 154.0M | 293.2M | 175.5M | 244.4M | 281.1M | 152.1M | |
Long Term Debt | 334.5M | 305.4M | 268.8M | 377.5M | 478.0M | 501.9M | |
Property Plant Equipment | 453.6M | 468.2M | 453.7M | 444.8M | 511.5M | 275.1M | |
Current Deferred Revenue | 20.2M | 35.1M | 33.1M | 27.1M | 20.4M | 17.9M | |
Short Term Investments | 8.4M | 21.2M | 15.2M | 13.8M | 11.8M | 13.7M | |
Treasury Stock | (1.3B) | (1.3B) | (1.5B) | (1.5B) | (1.4B) | (1.3B) | |
Net Tangible Assets | 875.3M | 894.3M | 912.8M | 897.3M | 1.0B | 829.4M | |
Retained Earnings Total Equity | 1.7B | 1.8B | 1.9B | 1.9B | 2.2B | 1.6B | |
Long Term Debt Total | 334.5M | 313.1M | 274.1M | 389.6M | 448.0M | 321.7M | |
Capital Surpluse | 557.5M | 579.8M | 601.7M | 613.3M | 705.3M | 500.0M | |
Non Current Liabilities Other | 105.7M | 112.3M | 88.8M | 76.5M | 9.0M | 8.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for NUS Stock analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Dividend Share 1.56 | Earnings Share 0.17 | Revenue Per Share 39.612 | Quarterly Revenue Growth (0.07) |
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.